Erysipelas
8
1
1
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
38%
3 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Comparing Short to Standard Amoxicillin Course for Erysipelas
Hospital at Home for Elderly Acute Ill Patients
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever
A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study
Duration of ANtibiotic Therapy for CEllulitis
The Use of Oral Steroids in the Treatment of Cellulitis
Short Course of Amoxicillin for Erysipelas